Byetta Added to Type 2 Regimens Improves Control

From the Spring Research Guide

| Apr 1, 2006

A recent study compared the effect of adding exenatide (Byetta) or insulin glargine (Lantus) to type 2 patients’ treatment regimens. The type 2s previously had been taking metformin and a sulfonylurea with little success.

According to the researchers, patients taking Byetta at dosages of 10 micrograms twice daily achieved reductions in glucose measures similar to those of patients taking Lantus.

“[Byetta] reduced postprandial glucose excursions more than insulin glargine, while insulin glargine reduced fasting glucose concentrations more than [Byetta],” write the researchers.

Byetta patients also lost an average of 5 pounds, while patients on Lantus gained an average of 4 pounds. Rates of symptomatic hypoglycemia were similar between treatment groups.

The most common adverse event for Byetta users was nausea, which was experienced by 57 percent of the participants. Six percent of Byetta participants discontinued its use due to nausea.

Annals of Internal Medicine, October 18, 2005

Click Here To View Or Post Comments

Categories: Byetta, Insulin, Lantus, Low Blood Sugar, Professional Issues, Type 2 Issues

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...

Click Here To View Or Post Comments

Apr 1, 2006

©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.